Phase II Study of Gemcitabine plus Cisplatin in Patients with Anthracycline- and Taxane- Pretreated Metastatic Breast Cancer

PURPOSE: Metastatic breast cancer patients are usually exposed to taxane and anthracycline as neoadjuvant, adjuvant and palliative chemotherapeutic agents. This study was designed to determine the efficacy and safety of the use of a gemcitabine and cisplatin (GP) combination treatment in patients wi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Kim, Jung Hwan, Oh, Sung Yong, Kwon, Hyuk-Chan, Lee, Suee, Kim, Sung-Hyun, Kim, Dae-Cheol, Lee, Jin-Hwa, Lee, Hyung-Sik, Cho, Se-Heun, Kim, Hyo-Jin
Format: Artigo
Sprache:Inglês
Veröffentlicht: Korean Cancer Association 2008
Schlagworte:
Original Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC2697461/
https://ncbi.nlm.nih.gov/pubmed/19688114
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4143/crt.2008.40.3.101
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge